Market Research Reports

The global Bone Morphogenetic Protein Market is set to witness a higher CAGR during the forecast period. Molecular cloning of bone morphogenetic proteins validate their family of differentiation factors and each capable of stimulating the development of new bone tissue once implanted. Morphogenetic based products are a revolution for several therapies in orthopaedic practices. Technically, bone matrix comprises a diversity of protein components entailing an array of growth and differentiation factors. Developments in the biochemical techniques and inception of biotechnology certainly allows purification followed by molecular cloning

Driving factors for bone morphogenetic proteins market include rise in number of patients with spinal injuries along with an increase in surgical rate. Rise in spinal fusion, small bone surgeries and trauma are likely to propel the market growth in the forecast period. Low back pain is one of the main reasons occurring due to lifestyle disorders resulting into severe back conditions. Subsequently, the rise in orthopaedic surgeries growing by number is likely to gain a significant attention in the forecast period. By Type, the market is segmented as rhBMP-2 and rhBMP-7. Application segment for bone morphogenetic protein market includes trauma, spinal fusion, reconstructive surgery and oral-maxillofacial.

Download Full Research Report on Bone Morphogenetic Protein Market @ https://www.millioninsights.com/industry-reports/bone-morphogenetic-proteins-market

Geographical segmentation for bone morphogenetic protein (BMP) market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. Asia-Pacific regions are likely to gain a significant market growth due to rise in orthopaedic conditions and change in lifestyle. Favorable reimbursement is a major reason for market development.

North American and European regions are likely to attain higher position due to rise in minimally invasive surgeries, higher recovery time and rise in geriatric population. In addition, rise in awareness about alternatives for bone grafting is contributing to the market growth. The key players in the bone morphogenetic protein industry include Medtronic, R&D Systems, Sigma Aldrich Corp, ProSpec, DePuySynthes, Ember Therapeutics Inc and Cellumed Co Ltd.

Market Segment:

Type Outlook (Market Revenue in USD Million, 2013 - 2024)
• rhBMP-2
• rhBMP-7

Application Outlook (Market Revenue in USD Million, 2013 - 2024)
• Spinal fusion
• Trauma
• Reconstruction
• Oral Maxillofacial

Request a Free Sample Copy of Bone Morphogenetic Protein Market Report @ https://www.millioninsights.com/industry-reports/bone-morphogenetic-proteins-market/request-sample

Regional Outlook (Market Revenue in USD Million, 2013 - 2024)
• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa